EMEA-000551-PIP04-21-M03 - paediatric investigation plan
Givinostat
PIPHuman
Key facts
- Active Substance
- Givinostat
- Therapeutic area
- Congenital, familial and genetic disorders
- Decision number
- P/0055/2024
- PIP number
- EMEA-000551-PIP04-21-M03
- Pharmaceutical form(s)
- Oral suspension
- Condition(s) / indication(s)
- Treatment of Duchenne muscular dystrophy
- Route(s) of administration
- Oral use
- Contact for public enquiries
Italfarmaco S.p.A.
E-mail: ITFPIP@italfarmacogroup.com
Tel. +39 0264432500
- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date